Canadian Diabetes Risk Assessment Questionnaire (CANRISK)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–20
- Moderate Risk21–32
- High Risk33–86
The Canadian Diabetes Risk Assessment Questionnaire (CANRISK) calculates evaluating glycemic control, metabolic decompensation severity, and long-term endocrine risks. Key inputs include age. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
CANRISK screens for undiagnosed type 2 diabetes mellitus and prediabetes in Canadian adults aged 18-74 years. It was developed by the Canadian Task Force on Preventive Health Care in partnership with the Public Health Agency of Canada and has been validated in Canada's multi-ethnic population.
Clinical Indication
The Canadian Diabetes Risk Assessment Questionnaire (CANRISK) is indicated for bedside clinical practice to support CANRISK screens for undiagnosed type 2 diabetes mellitus and prediabetes in Canadian adults aged 18-74 years. It was developed by the Canadian Task Force on Preventive Health Care in partnership with the Public Health Agency of Canada and has been validated in Canada's multi-ethnic population.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management.
Sum of points from: age (0-15) + gender (0-6) + BMI (0-14) + waist circumference (0-6) + physical activity (0-1) + diet (0-2) + blood pressure (0-4) + blood sugar (0-14) + large baby (0-1) + family history (0-8) + ethnicity (0-11)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | string | Yes | Age range of the patient |
| gender | string | Yes | Biological sex of the patient |
| bmi | string | Yes | Body Mass Index (kg/m²) category |
| waist_circumference | string | Yes | Waist circumference measured at belly button level |
| physical_activity | string | Yes | Do you do at least 30 minutes of physical activity every day? (e.g., brisk walking, gardening, cleaning, etc.) |
| vegetable_fruit_consumption | string | Yes | How often do you eat vegetables or fruits? |
| high_blood_pressure | string | Yes | Have you ever been told by a doctor or nurse that you have high blood pressure OR have you ever taken high blood pressure medication? |
| high_blood_sugar | string | Yes | Have you ever been found to have high blood sugar? (e.g., in a health examination, during an illness, during pregnancy) |
| large_baby | string | Yes | Have you ever given birth to a large baby weighing 4 kg (9 lbs) or more? (Females only) |
| family_diabetes | string | Yes | Do you have a mother, father, sister, or brother with diabetes? |
| ethnicity | string | Yes | What ethnic group does your biological (blood) mother and/or father belong to? If more than one group applies, choose the one with the highest score |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–20 | Low Risk | Low risk of type 2 diabetes |
| 21–32 | Moderate Risk | Moderate risk of type 2 diabetes |
| 33–86 | High Risk | High risk of type 2 diabetes |
Evidence-Based References (EBM)
- Robinson CA, Agarwal G, Nerenberg K. Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population. Chronic Dis Inj Can. 2011 Dec;32(1):19-31. PMID: 22153173.PMID: 22153173
- Public Health Agency of Canada. CANRISK: The Canadian Diabetes Risk Questionnaire User Guide for Pharmacists. Ottawa: Public Health Agency of Canada; 2011.
- Anand SS, Samaan Z, Middleton C, Irvine J, Desai D, Schulze KM, et al. A digital health intervention to lower cardiovascular risk: a randomized clinical trial. JAMA Cardiol. 2016 Aug 1;1(5):601-6. doi: 10.1001/jamacardio.2016.1035.DOI: 10.1001/jamacardio.2016.1035